Desi biopharma player Celon Laboratories develops alternative jab for black fungus

The company said it was able to develop the emulsion-based formulation for the drug in-house in just three weeks and has a capacity to manufacture 10,000 vials per day, which will be enough to cater to nearly 6,000 patients per month.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3c49cPB
via IFTTT